Stereotaxis, Inc. (NYSEAMERICAN:STXS) Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its position in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 463.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 134,822 shares of the company’s stock after buying an additional 110,909 shares during the period. JPMorgan Chase & Co. owned approximately 0.16% of Stereotaxis worth $307,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of STXS. Geode Capital Management LLC boosted its stake in Stereotaxis by 7.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock valued at $2,840,000 after acquiring an additional 93,253 shares during the last quarter. State Street Corp lifted its position in shares of Stereotaxis by 5.7% during the third quarter. State Street Corp now owns 680,612 shares of the company’s stock worth $1,388,000 after purchasing an additional 36,518 shares during the last quarter. Bank of New York Mellon Corp grew its stake in Stereotaxis by 13.0% in the fourth quarter. Bank of New York Mellon Corp now owns 193,109 shares of the company’s stock worth $440,000 after purchasing an additional 22,280 shares in the last quarter. Traynor Capital Management Inc. bought a new stake in Stereotaxis in the fourth quarter valued at about $366,000. Finally, Kovack Advisors Inc. raised its stake in Stereotaxis by 8.0% during the fourth quarter. Kovack Advisors Inc. now owns 133,792 shares of the company’s stock valued at $305,000 after buying an additional 9,917 shares in the last quarter. 45.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Stereotaxis news, Director Paul J. Isaac purchased 23,299 shares of Stereotaxis stock in a transaction on Thursday, March 6th. The stock was bought at an average price of $1.81 per share, for a total transaction of $42,171.19. Following the transaction, the director now owns 49,066 shares of the company’s stock, valued at $88,809.46. The trade was a 90.42 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 18.52% of the company’s stock.

Stereotaxis Stock Performance

NYSEAMERICAN STXS opened at $2.02 on Friday. The firm has a market capitalization of $171.15 million, a PE ratio of -7.21 and a beta of 1.54. Stereotaxis, Inc. has a one year low of $1.54 and a one year high of $2.72. The company has a 50-day simple moving average of $1.90 and a 200-day simple moving average of $2.07.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.